Skip to main content

Table 1 Admission demographic, clinical and laboratory details for patients included in the study on thiamin treatment and Plasmodium falciparum malaria in Laos

From: Thiamin supplementation does not reduce the frequency of adverse events after anti-malarial therapy among patients with falciparum malaria in southern Laos

Variables

Treatment groups

 

All (N = 630)

Thiamin (n = 314)

Placebo (n = 316)

Sex, M, no (%)

317 (50)

155 (49)

162 (51)

Age, years, median (range)

8 (0.5 – 73)

9 (0.5 – 63)

8 (0.7 – 73)

No. (%) patients aged <15 years

414 (66)

204 (65)

210 (66)

Body weight, kg

28.1 (26.8 – 29.4)

28.7 (26.8 – 30.7)

27.5 (25.6 – 29.3)

Height, cm

122.1 (119.9 – 124.4)

122.8 (119.5 – 126.0)

121.5 (118.5 – 124.8)

Previous malaria attack, no. (%) of patientsa

166 (26)

85 (27)

81 (26)

Axillary temperature, °C

38.4 (38.3 – 38.5)

38.4 (38.3 – 38.5)

38.5 (38.3 – 38.6)

Patients without fever on admission, no. (%)

159 (25)

85 (27)

74 (23)

Systolic blood pressure, mm Hg

100.8 (99.8 – 101.9)

100.7 (99.2 – 102.2)

100.9 (99.4 – 102.4)

Diastolic blood pressure, mm Hg

68.8 (68.0 – 69.7)

68.9 (67.6 – 70.1)

68.8 (67.7 – 70.0)

Pulse, beats/min

96.4 (95.2 – 97.5)

96.0 (94.4 – 97.6)

96.7 (95.2 – 98.3)

Respiratory rate/min

28.1 (27.6 – 28.6)

27.8 (27.1 – 28.6)

28.4 (27.7 – 29.1)

Glasgow coma score, median (range)

15 (4 – 15)

15 (12 – 15)

15 (4 – 15)

Severe malaria, no. (%) [WHO, 2000]

34 (5)

18 (6)

16 (5)

Pregnancy, no. (%)

29 (5)

13 (4)

16 (5)

Headache visual analogue score*

5.2 (5.0 – 5.5)

5.3 (5.0 – 5.7)

5.1 (4.7 – 5.7)

Dizziness visual analogue score, median (range)*

4 (0 – 10)

4 (0 – 10)

4 (0 – 10)

Splenomegaly, no. (%) of patients

163/628 (26)

85/313 (27)

78/315 (25)

Hepatomegaly, no (%) of patients

143/627 (23)

63/313 (20)

80/314 (25)

Lymphadenopathy, no (%) of patients

2/629 (0.3%)

1/313 (0.3%)

1/316 (0.3)

Parasitaemia, geometric mean parasites/μL (95%CI)

25,677 (22,350 – 29,499)

27,775 (22,995 – 33,549)

23,750 (19,369 – 29,123)

Mixed malaria species infection, no. (%)

11 (2)

5 (2)

6 (2)

Gametocytaemia, no. (%) of patients

27 (4)

14 (4)

13 (4)

Gametocytaemia, geometric mean parasite/μL (95%CI)

255 (125 – 521)

198 (78 – 503)

334 (98 – 1,134)

Haematocrit, %

35.6 (35.0 – 36.1)

35.6 (34.8 – 36.4)

35.5 (34.7 – 36.3)

Glucose, mmol/L

6.1 (6.0 – 6.2)

6.2 (6.1 – 6.3)

6.0 (5.9 – 6.2)

Lactate, mmol/L

3.2 (3.1 – 3.3)

3.1 (3.0 – 3.2)

3.3 (3.1 – 3.4)

  1. NOTE. Data are presented as mean values (95%CI), unless otherwise indicated. aDefined as patient or patient’s guardian reporting that the patient had had a febrile illness with a positive malaria slide. *Only children aged ≥ 4 years were asked about these symptoms.